Summary by Moomoo AI
Kexing Pharmaceutical Holdings Co., Ltd. (Kexing Pharmaceutical-B) submitted the disclosure report for the next day on June 19, 2024, disclosing the change in its shareholding. According to the Securities Listing Rules of The Stock Exchange of Hong Kong Limited (HKEX), the company's issued shares or treasury shares remained unchanged, with a balance of 575,653,415 shares. However, the company repurchased shares several times between May 31, 2024 and June 19, 2024, with a total repurchased number of 2,740,000 shares and repurchase price ranging from HKD 5.36 to HKD 6.99. The latest share repurchase occurred on June 19, 2024, repurchasing 700,000 shares at a price between HKD 5.47 and HKD 5.76, with a total payment of HKD 3,979,995. The company confirmed that all share repurchases were conducted in accordance with the regulations and there were no significant changes. In addition, the company will not issue any new shares or resell or transfer treasury shares within 30 days after the share repurchase, namely until July 19, 2024.